Literature DB >> 23011022

[Application of digital pathology tools. An unusual case of non-Hodgkin lymphoma].

A-S K Meyer1, F E Dallenbach, G Lienert, P Möller, J K Lennerz.   

Abstract

Currently, lymphoma diagnosis is based on a combination of morphology, immunophenotyping, and molecular testing. Using the example of an unusual case of malignant non-Hodgkin lymphoma, we show that improved visualization using digital pathology contributes to the convergence of these complementary diagnostic modalities. A 45-year-old woman presented with skin rash and cervical lymphadenopathy. Histological workup of an excised lymph node showed loss of normal architecture with diffuse infiltration and increased mitotic activity. Immunohistochemistry for CD3/CD5 showed atypical arrangement and infiltration of a T-cell population that dominated over regionally dense, MUM1-positive plasmacellular infiltrates. Expanded CD21/CD23-positive meshworks of follicular dendritic cells were present within and between regressed follicles and the T-cell infiltrate; staining for CD56 and cyclin-D1 was negative. Quantification of Ki-67 staining within the T-, B- and plasmacellular compartments was achieved by digital image conversion, overlay and subsequent quantification algorithms that revealed proliferation within more than 60% of T-cells, over 50% of plasma cells and only 20% of B-cells. Clonality analysis by PCR revealed monoclonal rearrangement for both T-cell receptor gamma chains and immunoglobulin heavy chains. Taken together, we present an unusual combination of an angioimmunoblastic T-cell lymphoma (AITL) and simultaneous plasmacellular lymphoma. This report demonstrates how application of modern tools of digital pathology can visually integrate unusual morphological and molecular findings.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23011022     DOI: 10.1007/s00292-012-1674-9

Source DB:  PubMed          Journal:  Pathologe        ISSN: 0172-8113            Impact factor:   1.011


  25 in total

1.  Epstein-Barr virus-associated B-cell lymphoproliferative disorders in angloimmunoblastic T-cell lymphoma and peripheral T-cell lymphoma, unspecified.

Authors:  Andreas Zettl; Seung-Sok Lee; Thomas Rüdiger; Petr Starostik; Mirella Marino; Thomas Kirchner; Michaela Ott; Hans Konrad Müller-Hermelink; German Ott
Journal:  Am J Clin Pathol       Date:  2002-03       Impact factor: 2.493

2.  The frequency of B- and T-cell gene rearrangements and epstein-barr virus in T-cell lymphomas: a comparison between angioimmunoblastic T-cell lymphoma and peripheral T-cell lymphoma, unspecified with and without associated B-cell proliferations.

Authors:  Brenton T Tan; Roger A Warnke; Daniel A Arber
Journal:  J Mol Diagn       Date:  2006-09       Impact factor: 5.568

3.  Evidence for monoclonal T lymphocyte proliferation in angioimmunoblastic lymphadenopathy.

Authors:  N T O'Connor; J A Crick; J S Wainscoat; K C Gatter; H Stein; B Falini; D Y Mason
Journal:  J Clin Pathol       Date:  1986-11       Impact factor: 3.411

4.  Angioimmunoblastic lymphadenopathy evolution to a Burkitt-like lymphoma.

Authors:  E M Mazur; D H Lovett; R E Enriquez; W R Breg; R J Papac
Journal:  Am J Med       Date:  1979-08       Impact factor: 4.965

5.  The transcription factor MIST1 is a novel human gastric chief cell marker whose expression is lost in metaplasia, dysplasia, and carcinoma.

Authors:  Jochen K M Lennerz; Seok-Hyung Kim; Edward L Oates; Won Jae Huh; Jason M Doherty; Xiaolin Tian; Andrew J Bredemeyer; James R Goldenring; Gregory Y Lauwers; Young-Kee Shin; Jason C Mills
Journal:  Am J Pathol       Date:  2010-08-13       Impact factor: 4.307

6.  Histologic evolution of angioimmunoblastic T-cell lymphoma in consecutive biopsies: clinical correlation and insights into natural history and disease progression.

Authors:  Ayoma Deepthi Attygalle; Charalampia Kyriakou; Jehan Dupuis; Karen Lynne Grogg; Timothy Charles Diss; Andrew Charles Wotherspoon; Shih Sung Chuang; José Cabeçadas; Peter Gershon Isaacson; Ming-Qing Du; Philippe Gaulard; Ahmet Dogan
Journal:  Am J Surg Pathol       Date:  2007-07       Impact factor: 6.394

7.  Epstein-Barr virus negative clonal plasma cell proliferations and lymphomas in peripheral T-cell lymphomas: a phenomenon with distinctive clinicopathologic features.

Authors:  Olga Balagué; Antonio Martínez; Luís Colomo; Ester Roselló; Adriana Garcia; Mónica Martínez-Bernal; Antonio Palacín; Kai Fu; Dennis Weisenburger; Dolors Colomer; Jerome S Burke; Roger A Warnke; Elías Campo
Journal:  Am J Surg Pathol       Date:  2007-09       Impact factor: 6.394

8.  Long-term disease-free survival in patients with angioimmunoblastic T-cell lymphoma after high-dose chemotherapy and autologous stem cell transplantation.

Authors:  Johannes Schetelig; Sebastian Fetscher; Albrecht Reichle; Wolfgang E Berdel; Yves Beguin; Salut Brunet; Dolores Caballero; Ignazio Majolino; Hans Hagberg; Hans E Johnsen; Eva Kimby; Emilio Montserrat; Douglas Stewart; Adrian Copplestone; Wolf Rösler; Jindra Pavel; Dorothea Kingreen; Wolfgang Siegert
Journal:  Haematologica       Date:  2003-11       Impact factor: 9.941

Review 9.  Angioimmunoblastic T cell lymphoma: pathobiological insights and clinical implications.

Authors:  Kieron Dunleavy; Wyndham H Wilson; Elaine S Jaffe
Journal:  Curr Opin Hematol       Date:  2007-07       Impact factor: 3.284

10.  Monoclonal evolution of angioimmunoblastic lymphadenopathy.

Authors:  L Boros; A G Bhaskar; J P D'Souza
Journal:  Am J Clin Pathol       Date:  1981-06       Impact factor: 2.493

View more
  2 in total

1.  [Application of digital pathology tools. An unusual case of non-Hodgkin lymphoma].

Authors:  A-S K Meyer; F E Dallenbach; G Lienert; P Möller; J K Lennerz
Journal:  Pathologe       Date:  2012-11       Impact factor: 1.011

2.  A nuclear circularity-based classifier for diagnostic distinction of desmoplastic from spindle cell melanoma in digitized histological images.

Authors:  Manuel Schöchlin; Stephanie E Weissinger; Arnd R Brandes; Markus Herrmann; Peter Möller; Jochen K Lennerz
Journal:  J Pathol Inform       Date:  2014-10-21
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.